Shan Lu

Shan Lu

Auto-generated profile, based on publicly available information

Shan Lu

National Engineering Research Center of Human Stem Cells, Changsha, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in Regenerative Therapy
Verified
Journal Article
Open access
WZWang Zhou
Wang Zhou
YCYujiao Chai
Yujiao Chai
SLShan Lu
Shan Lu
QYQiaohui Yang
Qiaohui Yang
LTLiying Tang
Liying Tang
DZDi Zhou
Di Zhou
Regarded as the most promising treatment modality for retinal degenerative diseases, retinal pigment epithelium cell replacement therapy holds significant potential. Common retinal degenerative diseases, including Age-related Macular Degeneration, are frequently characterized by damage to the unit comprising photoreceptors, retinal pigment epithelium, and Bruch's membrane. The selection of appropriate tissue engineering materials, in conjunction with retinal pigment epithelial cells, for graft preparation, can offer an effective treatment for retinal degenerative diseases. This article presents an overview of the research conducted on retinal pigment epithelial cell tissue engineering, outlining the challenges and future prospects.